암성 악액질의 최신 지견 = Recent Advances in Cancer Cachexia

다국어 초록 (Multilingual Abstract)

Purpose: The study was aimed to review and understand the meaning of cancer cachexia. Methods: Using the keywords “cachexia” and “cancer cachexia” 30 oncology research published from 1974 to 2009 were selected for the review. Results: The mechanism of cancer cachexia has not been fully understood, but various pathogenesis appears to be involved in the development cachexia including altered metabolism of carbohydrate, lipid, and protein associated with cytokines and hormone. As a result, muscle strength, food intake and resting energy expenditure (REE) are reduced. Most medications for the treatment of cachexia show debating results except some drugs such as megace. Supportive care including nutritional education, nursing care, and social support are found another effective treatment options. Conclusion: The results of this study would help oncology nurses to understand the mechanism of cancer cachexia and its management.

목차 (Table of Contents)

• 서론
• 결론
• 참고문헌

참고문헌 (Reference)

1 Larkin M, "Thwarting the dwindling progressionof cachexia" 351 : 1336-, 1998

2 Body JJ, "The syndrome of anorexia-cachexia" 11 : 255-260, 1999

3 Reid J, "The experience of cancer cachexia:A qualitative study of advanced cancer patients and their family members" 46 : 606-616, 2009

4 Nelson KA, "The cancer anorexia-cachexia syndrome" 12 : 213-225, 1994

5 Nelson KA, "The cancer anorexia-cachexia syndrome" 12 : 213-225, 1994

6 Gordon JN, "Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial" 54 : 540-545, 2005

7 Sanchis D, "Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model" 436 : 415-418, 1998

8 Edelman MJ, "Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome" 86 : 684-688, 1999

9 Wisse BE, "Reversal of cancer anorexia by blockade of central melanocortin receptors in rats" 142 : 3292-3301, 2001

10 Lai V, "Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract" 30 : 67-74, 2008

11 Tisdale MJ, "Protein loss in cancer cachexia" 289 : 2293-2294, 2000

12 Loprinzi CL, "Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia" 11 : 762-767, 1993

13 Popiera T, "Methylprednisolone as palliative therapy for female terminal cancer patients" 25 : 1823-1829, 1989

14 Tisdale MJ, "Metabolic abnormalities in cachexia and anorexia" 16 : 1013-1014, 2000

15 Friedman JM, "Leptin and the regulation of body weight in mammals" 395 : 763-770, 1998

16 Lissoni1 P, "Is there a role for melatonin in the treatment of neoplastic cachexia" 32 : 1340-1343, 1996

17 Suto G, "IL-1b inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor" 106 : 1568-1575, 1994

18 Inui A, "Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin" 22 : 62-67, 1999

19 Pedersen BK, "Exercise immunology" Chapman & Hall 1997

20 Fearon KC, "Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial" 52 : 1479-1486, 2003

21 Bozzetti F, "Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group" 33 : 361-367, 2009

22 Moertel CG, "Corticosteroid therapy of preterminal gastrointestinal cancer" 33 : 1607-1609, 1974

23 Tisdale MJ, "Cancer anorexia and cachexia" 17 : 438-442, 2001

24 Evans WJ, "Cachexia: a new definition" 27 : 793-799, 2008

25 Shellock FG, "Brwon adipose tissue in cancer patients: possible cause of cancer-induced cachexia" 111 : 82-85, 1986

26 Loprinzi CL, "Body-composition changes in patients who gain weight while receiving megestrol acetate" 11 : 152-154, 1993

27 Slaviero KA, "Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy" 46 : 148-157, 2003

28 Bruera E, "Anorexia, cachexia and nutrition" 315 : 1219-1222, 1997

29 Perboni S, "Anorexia in cancer: role of feedeing-regulatory peptides" 361 : 1281-1289, 2006

30 Lesser GJ, "A phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on lean body mass (LBM), weight (wt) and quality of life (QOL) in patients with solid tumors and weight loss receiving chemotherapy" 26 : 505-, 2008